Cargando…

Circulating mitochondrial DNA as a biomarker for lung cancer screening

Detalles Bibliográficos
Autores principales:	von Itzstein, Mitchell S., Gerber, David E., Minna, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459621/ https://www.ncbi.nlm.nih.gov/pubmed/36090641 http://dx.doi.org/10.21037/tlcr-22-511

Ejemplares similares

Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

How lung cancer cells change identity
por: von Itzstein, Mitchell S, et al.
Publicado: (2021)

Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
por: Gonugunta, Amrit S., et al.
Publicado: (2022)

Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?
por: Kandel, Eugene S.
Publicado: (2012)

Circulating Cancer Biomarkers
por: Lokshin, Anna, et al.
Publicado: (2021)

Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality?
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

Closing the gap: Contribution of surgical best practices to outcome differences between high‐ and low‐volume centers for lung cancer resection
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Systemic and Intracranial Efficacy of Osimertinib in EGFR L747P-Mutant NSCLC: Case Report
por: Gerber, David E., et al.
Publicado: (2022)

Biomarkers and the Fontan Circulation
por: Schumacher, Kurt R., et al.
Publicado: (2016)

Cellular senescence and lung cancer prognosis
por: Asaithamby, Aroumougame, et al.
Publicado: (2022)

Circulating Tumor DNA Testing for Liver Cancer
por: Furtado, Larissa V., et al.
Publicado: (2015)

Biomarkers in colorectal cancer screening
por: Schab, Katarzyna, et al.
Publicado: (2017)

Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?
por: Ligi, D, et al.
Publicado: (2016)

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection
por: Zhou, Huifen, et al.
Publicado: (2023)

Circulating Biomarkers in Cardiovascular Disease
por: Ingelsson, Erik
Publicado: (2009)

Year of Expanding into Circulating Biomarkers
por: Jia, Shidong, et al.
Publicado: (2015)

Distinct NSCLC EGFR Variants in a Family With Li-Fraumeni Syndrome: Case Report
por: Edmondson, Shelby, et al.
Publicado: (2022)

Saudi lung cancer prevention and screening guidelines
por: Howington, John
Publicado: (2018)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Circulating DNA fragmentomics and cancer screening
por: Thierry, A.R.
Publicado: (2023)

The Role of Circulating Biomarkers in Lung Cancer
por: Herath, Sayuri, et al.
Publicado: (2022)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma
por: Kurtz, David M.
Publicado: (2021)

Olfactomedin 4 as a circulating biomarker for asthma
por: Jang, An-Soo
Publicado: (2022)

The quest for a biomarker of circulating osteoclast precursors
por: Ritchlin, Christopher
Publicado: (2009)

DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation
por: Juvet, Stephen, et al.
Publicado: (2020)

Diagnostic and Predictive Biomarkers in Lung Cancer
por: Fumagalli, Caterina, et al.
Publicado: (2021)

Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)
por: Kramer, Barnett S, et al.
Publicado: (2011)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

The Uprising of Mitochondrial DNA Biomarker in Cancer
por: Mohd Khair, Siti Zulaikha Nashwa, et al.
Publicado: (2021)

Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells
por: Raymond, Aaron C., et al.
Publicado: (2019)

Using mitochondrial DNA as a biosensor of early cancer development
por: Birch-Machin, M A
Publicado: (2005)

Mitochondrial mass and DNA repair in breast cancer stem cells
por: Pestell, Richard G., et al.
Publicado: (2015)

Circulating tumour DNA analysis in multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2017)

Detection of circulating tumor DNA for advanced bladder cancer: where are we going?
por: Morales-Barrera, Rafael, et al.
Publicado: (2018)

Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
por: Rashdan, Sawsan, et al.
Publicado: (2021)

Lung function impairment in lung cancer screening: discordance between risk and screening outcomes when looking through a PRISm
por: Young, Robert P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3heftkicg05cl20o7i10dj2b4t